ID   MDA-T68
AC   CVCL_QW83
DR   ATCC; CRL-3353
DR   cancercelllines; CVCL_QW83
DR   Cosmic; 2612756
DR   Wikidata; Q54904662
RX   PubMed=25427145;
CC   Population: Caucasian.
CC   Doubling time: ~45 hours (ATCC=CRL-3353).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=25427145).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (PubMed=25427145).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): ATCC=CRL-3353; PubMed=25427145
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 9,12
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 9,12
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 18
DI   NCIt; C8054; Thyroid gland follicular carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 13
//
RX   PubMed=25427145; DOI=10.1210/jc.2014-2624; PMCID=PMC4318904;
RA   Henderson Y.C., Ahn S.-H., Ryu J., Chen Y.-Y., Williams M.D.,
RA   El-Naggar A.K., Gagea M., Schweppe R.E., Haugen B.R., Lai S.Y.,
RA   Clayman G.L.;
RT   "Development and characterization of six new human papillary thyroid
RT   carcinoma cell lines.";
RL   J. Clin. Endocrinol. Metab. 100:E243-E252(2015).
//